Noninvasive Genomic Profiling Identifies Unique Hodgkin Lymphoma Subtypes

Researchers have identified distinct subtypes of Hodgkin lymphoma using noninvasive genomic profiling, which could help guide personalized treatment strategies for patients. The study analyzed tumor samples from over 1,000 patients and identified five distinct subtypes based on their genetic characteristics. These subtypes were associated with different clinical outcomes and response to treatment. The findings highlight the potential of genomic profiling in improving the precision of cancer care and tailoring therapies to individual patients.